22 results on '"Croker, Daniel"'
Search Results
2. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
3. Derivation of ligands for the complement C3a receptor from the C-terminus of C5a
4. C5a2 can modulate ERK1/2 signaling in macrophages via heteromer formation with C5a1 and β-arrestin recruitment
5. C5a, but not C5a-des Arg, induces upregulation of heteromer formation between complement C5a receptors C5aR and C5L2
6. Glucocorticoid‐Receptor Mediated Signaling Regulates Lipolysis in Northern Elephant Seal Pups
7. Adrenocorticotropin Infusion Stimulates Glucocorticoid‐Receptor Mediated Lipolysis in Northern Elephant Seal Pups.
8. Identification, Synthesis, and Biological Evaluation of the Major Human Metabolite of NLRP3 Inflammasome Inhibitor MCC950
9. Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling
10. Conopeptide-Derived κ-Opioid Agonists (Conorphins): Potent, Selective, and Metabolic Stable Dynorphin A Mimetics with Antinociceptive Properties
11. 30
12. 32
13. Ligand-induced dimerisation of the complement C5aR and C5L2 receptors by C5a but not C5a-des Arg
14. A Comparative Study of Impedance versus Optical Label-Free Systems Relative to Labelled Assays in a Predominantly Gi Coupled GPCR (C5aR) Signalling
15. Mapping the signalling pathways and interactions for the complement C5a receptors using novel methodologies
16. χ-Conopeptide Pharmacophore Development: Toward a Novel Class of Norepinephrine Transporter Inhibitor (Xen2174) for Pain
17. Conopressin-T from Conus tulipa Reveals an Antagonist Switch in Vasopressin-like Peptides
18. 32: Discovery of novel selective C5a2 ligands that can modulate IL-6 release from macrophages
19. 30: MCC950 is a potent and specific inhibitor of the NLRP3 inflammasome and a novel potential therapeutic for NLRP3 driven diseases
20. Allosteric α1-Adrenoreceptor Antagonism by the Conopeptide ρ-TIA
21. Allosteric α[sub 1]-Andrenoreceptor Antagonism by the Conopeptide ρ-TIA.
22. chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.